[go: up one dir, main page]

IL133709A0 - Device for optimized electrotransfer of nucleic acid vectors to tissues in vivo - Google Patents

Device for optimized electrotransfer of nucleic acid vectors to tissues in vivo

Info

Publication number
IL133709A0
IL133709A0 IL13370998A IL13370998A IL133709A0 IL 133709 A0 IL133709 A0 IL 133709A0 IL 13370998 A IL13370998 A IL 13370998A IL 13370998 A IL13370998 A IL 13370998A IL 133709 A0 IL133709 A0 IL 133709A0
Authority
IL
Israel
Prior art keywords
electrotransfer
tissues
vivo
optimized
nucleic acid
Prior art date
Application number
IL13370998A
Other languages
English (en)
Original Assignee
Rhone Poulence Rorer S A
Roussy Inst Gustave
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9708232A external-priority patent/FR2765241B1/fr
Priority claimed from FR9708233A external-priority patent/FR2765242B1/fr
Application filed by Rhone Poulence Rorer S A, Roussy Inst Gustave, Centre Nat Rech Scient filed Critical Rhone Poulence Rorer S A
Publication of IL133709A0 publication Critical patent/IL133709A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/325—Applying electric currents by contact electrodes alternating or intermittent currents for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Electrotherapy Devices (AREA)
IL13370998A 1997-06-30 1998-06-30 Device for optimized electrotransfer of nucleic acid vectors to tissues in vivo IL133709A0 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
FR9708232A FR2765241B1 (fr) 1997-06-30 1997-06-30 Amelioration du transfert d'acide nucleique dans les cellules d'organismes eucaryotes pluricellulaires et combinaison permettant la mise en oeuvre du procede
FR9708233A FR2765242B1 (fr) 1997-06-30 1997-06-30 Amelioration du transfert d'acide nucleique dans le muscle strie et combinaison permettant la mise en oeuvre du procede
US6748797P 1997-12-01 1997-12-01
US6748897P 1997-12-01 1997-12-01
US8385898P 1998-05-01 1998-05-01
PCT/EP1998/003976 WO1999001175A1 (fr) 1997-06-30 1998-06-30 Dispositif permettant un transfert in vivo optimise de vecteurs d'acides nucleiques dans des tissus

Publications (1)

Publication Number Publication Date
IL133709A0 true IL133709A0 (en) 2001-04-30

Family

ID=27515625

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13370998A IL133709A0 (en) 1997-06-30 1998-06-30 Device for optimized electrotransfer of nucleic acid vectors to tissues in vivo

Country Status (11)

Country Link
EP (1) EP0993318A1 (fr)
JP (1) JP2002515816A (fr)
KR (1) KR20010014298A (fr)
CN (1) CN1261812A (fr)
AU (1) AU8730798A (fr)
BR (1) BR9810500A (fr)
CA (1) CA2295029A1 (fr)
IL (1) IL133709A0 (fr)
NO (1) NO996540L (fr)
PL (1) PL337617A1 (fr)
WO (1) WO1999001175A1 (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2753379B1 (fr) 1996-09-13 1998-10-30 Rhone Poulenc Rorer Sa Methode de traitement de la sclerose laterale amyotrophique
US6261281B1 (en) 1997-04-03 2001-07-17 Electrofect As Method for genetic immunization and introduction of molecules into skeletal muscle and immune cells
CA2361601A1 (fr) * 1999-02-08 2000-08-10 Cheryl Goldbeck Augmentation electriquement induite de l'immunite et de l'efficacite de vaccins d'adn in vivo
ATE511856T1 (de) 2000-03-13 2011-06-15 Cornell Res Foundation Inc Blockieren der leukozytenemigration und entzündung durch störung mit cd99/hec2
IL151348A0 (en) 2000-04-13 2003-04-10 Univ Rockefeller Enhancement of antibody-mediated immune responses
AU2001264759B2 (en) 2000-05-22 2006-06-01 Merck & Co., Inc. System and method for assessing the performance of a pharmaceutical agent delivery system
KR20030074680A (ko) 2000-12-28 2003-09-19 와이어쓰 스트렙토코커스 뉴모니에 유래 재조합 보호 단백질
US20030039660A1 (en) 2001-03-02 2003-02-27 The Rockefeller University Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen
US20020198567A1 (en) * 2001-06-07 2002-12-26 Yona Keisari Electro-endocytotic therapy as a treatment modality of cancer
MX339524B (es) 2001-10-11 2016-05-30 Wyeth Corp Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
US20050154434A1 (en) 2002-03-07 2005-07-14 Adam Simon Clinical syringe with electrical stimulation aspects
NZ536475A (en) 2002-05-24 2008-06-30 Schering Corp Neutralizing human anti-igfr antibody
US7785608B2 (en) 2002-08-30 2010-08-31 Wyeth Holdings Corporation Immunogenic compositions for the prevention and treatment of meningococcal disease
EP1759714A1 (fr) * 2005-09-02 2007-03-07 Bioalliance Pharma Electrotransfert d'acides nucléiques dans des cellules tissulaires
JP2009520509A (ja) * 2005-10-03 2009-05-28 ノヴォキュアー・リミテッド 増殖細胞における電場の効果を増大させるための電場の最適化特性
JP4961137B2 (ja) * 2005-12-14 2012-06-27 久光製薬株式会社 イオントフォレーシス用デバイス
ES2501947T3 (es) 2006-10-19 2014-10-02 Csl Limited Antagonistas de anticuerpos de alta afinidad del receptor alfa 1 de interleucina
CA2666682C (fr) 2006-10-19 2014-07-08 Merck & Co., Inc. Anticorps diriges contre il-13r.alpha.1 et leurs utilisations
AR064642A1 (es) 2006-12-22 2009-04-15 Wyeth Corp Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
US8246176B2 (en) 2007-03-06 2012-08-21 Sanyo Electric Co., Ltd. Projection display device having an operation section for displacing a lens
US8093043B2 (en) 2008-06-04 2012-01-10 New York University β-TrCP1, β-TrCP2 and RSK1 or RSK2 inhibitors and methods for sensitizing target cells to apoptosis
CN102124102B (zh) * 2008-07-18 2013-12-18 麦克赛特股份有限公司 优化电穿孔的方法
NZ614064A (en) 2008-11-05 2015-04-24 Wyeth Llc Multicomponent immunogenic composition for the prevention of beta-hemolytic streptococcal (bhs) disease
HRP20210242T4 (hr) 2010-08-23 2024-05-10 Wyeth Llc Stabilne formulacije antigena iz bakterije neisseria meningitidis rlp2086
RU2546873C2 (ru) 2010-09-10 2015-04-10 УАЙТ ЭлЭлСи Нелипидизированные варианты антигенов neisseria meningitidis orf2086
SA115360586B1 (ar) 2012-03-09 2017-04-12 فايزر انك تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
JP5925342B2 (ja) 2012-03-09 2016-05-25 ファイザー・インク 髄膜炎菌（Ｎｅｉｓｓｅｒｉａｍｅｎｉｎｇｉｔｉｄｉｓ）組成物およびその方法
WO2014107739A1 (fr) 2013-01-07 2014-07-10 Eleven Biotherapeutics, Inc. Anticorps dirigés contre pcsk9
EP2964665B1 (fr) 2013-03-08 2018-08-01 Pfizer Inc Polypeptides immunogènes de fusion
MX380129B (es) 2013-09-08 2025-03-11 Pfizer Composiciones de neisseria meningitidis y sus metodos
RU2723045C2 (ru) 2015-02-19 2020-06-08 Пфайзер Инк. Композиции neisseria meningitidis и способы их получения
IL303108B2 (en) 2017-01-31 2024-07-01 Pfizer NEISSERIA MENINGITIDIS preparations and methods therefor
CN110527625A (zh) * 2018-05-24 2019-12-03 苏州壹达生物科技有限公司 一种结合高压和低压模式的流式电转染装置
US12383611B2 (en) 2019-09-27 2025-08-12 Pfizer Inc. Neisseria meningitidis compositions and methods thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9317380D0 (en) * 1993-08-20 1993-10-06 Therexsys Ltd Transfection process
US5641680A (en) * 1994-11-14 1997-06-24 Zhao; Xi Gene transfer apparatus and method for using the same
WO1997007826A1 (fr) * 1995-08-29 1997-03-06 Cbr Laboratories, Inc. Electroporation in vivo de cellules

Also Published As

Publication number Publication date
BR9810500A (pt) 2000-09-05
CA2295029A1 (fr) 1999-01-14
EP0993318A1 (fr) 2000-04-19
AU8730798A (en) 1999-01-25
KR20010014298A (ko) 2001-02-26
PL337617A1 (en) 2000-08-28
WO1999001175A1 (fr) 1999-01-14
NO996540D0 (no) 1999-12-29
JP2002515816A (ja) 2002-05-28
CN1261812A (zh) 2000-08-02
NO996540L (no) 2000-02-03

Similar Documents

Publication Publication Date Title
IL133709A0 (en) Device for optimized electrotransfer of nucleic acid vectors to tissues in vivo
HUP0001261A3 (en) Method of imaging cell death in vivo
GB2331247B (en) Improvements in relation to apparatus for surgical diathermy
AP2000001762A0 (en) Method of delivering genes to antigen presenting cells of the skin
PL316200A1 (en) Co-ordinated expression of genes in vivo
PL325821A1 (en) Liquid acid netralising preparation
GB9708512D0 (en) Improvements relating to skin prickers
HUP0002683A3 (en) Compositions and methods for enhancing delivery of therapeutic agents to cells
GB9515356D0 (en) Improvements in or relating to delivery of nucleic acid
GB2327815B (en) Terminal unit in which waterproof effect is improved
GB9717932D0 (en) Estimation of nucleic acid
AU6894298A (en) Human fatty acid binding protein
IL149506A0 (en) Human heparanase-related polypeptide and nucleic acid
GB9718320D0 (en) Improvements in or relating to gel loading
GB9705007D0 (en) Improvements in or relating to therapeutic genes
GB9715164D0 (en) Improvements in or relating to expression of nucleic acid sequences in cerebellar cells
GB2369500B (en) Terminal unit in which waterproof effect is improved
TW444691U (en) Improved structure of car power connector
GB9928530D0 (en) Constructs for delivery of therapeutic agents to neuronal cells
GB9711839D0 (en) Improvements in or relating to diagnostic/therapeutic agents
GB9711837D0 (en) Improvements in or relating to diagnostic / therapeutic agents
GB9711842D0 (en) Improvements in or relating to diagnostic/therapeutic agents
GB9711846D0 (en) Improvements in or relating to diagnostic/therapeutic agents
GB9711845D0 (en) Improvements in or relating to diagnostic/therapeutic agents
GB9711844D0 (en) Improvements in or relating to diagnostic/therapeutic agents